1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Sepsis Diagnostics Market - By Product
1.3.2 Global Sepsis Diagnostics Market - By Technology
1.3.3 Global Sepsis Diagnostics Market - By Method
1.3.4 Global Sepsis Diagnostics Market - By Test Type
1.3.5 Global Sepsis Diagnostics Market - By Pathogen
1.3.6 Global Sepsis Diagnostics Market - By End User
1.3.7 Global Sepsis Diagnostics Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Sepsis Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion
5. Sepsis Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. Sepsis Diagnostics Market- Global Analysis
6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
6.1.2 Market Positioning of Key Players
6.1.3 Global Sepsis Diagnostics market - Market Potential Analysis, By Region
6.2 Comparative Company Analysis
6.2.1 Growth Strategy Analysis
6.2.2 Performance of Key Players
6.2.2.1 BioM?rieux, Inc.
6.2.2.2 Danaher
6.2.3 Market Share Analysis of Sepsis Diagnostics Market
7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product
7.1 Overview
7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology
8.1 Overview
8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Real-Time Cell Analysis
8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
8.4.3.1.1 Characteristics of TaqMan Assays
8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
8.4.3.2.1 Abstract
8.4.3.2.2 Conclusion:
8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
8.4.3.4 Sepsis diagnosis by real-time PCR
8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Metabolomics
8.7.3.1 Metabolite Profile in Sepsis
8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
8.7.3.4.1 Genomics
8.7.3.4.2 Proteomics
8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
8.7.3.6 Role Metabolomics and Proteomics in Sepsis
8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
8.7.3.9 Metabolics in Mitochondrial Function
8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method
9.1 Overview
9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type
10.1 Overview
10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen
11.1 Overview
11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User
12.1 Overview
12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis
13.1 North America: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 North America: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.9.1 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.1 Overview
13.1.9.1.2 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.9.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.1 Overview
13.1.9.2.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028
13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.9.3 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.1 Overview
13.1.9.3.2 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028
13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.2 Europe: Sepsis Diagnostics Market
13.2.1 Overview
13.2.2 Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.3 Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.4 Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.4.1 Biomarkers: Metabolomics 2019-2028
13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.5 Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.6 Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.8 Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.2.9.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.1 Overview
13.2.9.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.1 Overview
13.2.9.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.1 Overview
13.2.9.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.1 Overview
13.2.9.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.1 Overview
13.2.9.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.1 Overview
13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028
13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.3 Asia Pacific: Sepsis Diagnostics Market
13.3.1 Overview
13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
13.3.4.1 Biomarkers: Metabolomics 2019-2028
13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.3.9.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.1.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9.2 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.2.1 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9.3 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.3.1 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9.4 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.4.1 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9.5 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.5.1 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028
13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028
13.4.1 Overview
13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.4.4.1 Biomarkers: Metabolomics 2019-2028
13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.1.1 Overview
13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028
13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.2.1 Overview
13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028
13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.3.1 Overview
13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028
13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.4.1 Overview
13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028
13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
13.5.1 Overview
13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.5.4.1 Biomarkers: Metabolomics 2019-2028
13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.5.9.1.1 Overview
13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)